Generated by GPT-5-mini| adenine | |
|---|---|
![]() Mikael Häggström · CC BY-SA 3.0 · source | |
| Name | Adenine |
| Caption | Structural formula of adenine |
| Formula | C5H5N5 |
| Molar mass | 135.13 g·mol−1 |
| Appearance | White crystalline |
| Melting point | 360 °C (decomp.) |
| Solubility | Soluble in water |
adenine Adenine is a purine nucleobase found in nucleic acids and numerous biomolecules. It participates in hydrogen bonding, forms canonical base pairs in DNA and RNA, and is a key moiety in energy transfer and signaling compounds. Widely studied across chemistry and biology, adenine links structural chemistry to cellular metabolism and genetic information flow.
Adenine is a bicyclic heterocycle composed of a pyrimidine ring fused to an imidazole ring, giving a planar aromatic scaffold. In solid-state and solution studies, researchers using techniques from Linus Pauling-era structural chemistry through modern X-ray crystallography and nuclear magnetic resonance spectroscopy have characterized its tautomeric forms and protonation states. Physical chemists and materials scientists in labs associated with institutions like Massachusetts Institute of Technology, University of Cambridge, and Max Planck Society have measured melting behavior, ultraviolet absorbance spectra, and hydrogen-bonding geometries relevant to supramolecular assemblies and nanotechnology applications. Computational groups at Stanford University, ETH Zurich, and Lawrence Berkeley National Laboratory apply quantum chemical methods to model stacking interactions and solvent effects, comparing results to experiments from groups at Brookhaven National Laboratory and California Institute of Technology.
Adenine appears in core biological molecules including DNA, RNA, adenosine triphosphate, and nicotinamide adenine dinucleotide. Enzymes of major families—such as polymerases characterized in research at Cold Spring Harbor Laboratory and European Molecular Biology Laboratory—recognize adenine-containing substrates during replication and transcription. Metabolic pathways cataloged in databases maintained by teams at National Institutes of Health and European Bioinformatics Institute show adenine-derived cofactors in redox reactions mediated by enzymes studied at Max Planck Institute for Biochemistry and Johns Hopkins University. Studies of cellular signaling by laboratories at Harvard University and University of Oxford highlight adenine-containing second messengers and their roles in pathways investigated in model organisms like Saccharomyces cerevisiae, Escherichia coli, and Drosophila melanogaster.
De novo purine biosynthesis pathways characterized in classic biochemical work at institutions such as Rockefeller University and University of California, San Francisco produce the adenine ring via multi-step transformations from phosphoribosyl pyrophosphate. Key enzymes—AMP synthase, adenylosuccinate lyase, and amidophosphoribosyltransferase—have been studied by molecular genetics groups at University of Chicago and Columbia University. Salvage pathways involving adenine phosphoribosyltransferase recycle adenine in organisms ranging from Homo sapiens to bacteria described in research at Pasteur Institute. Metabolic disorders implicating purine metabolism have been investigated clinically at centers including Mayo Clinic and Cleveland Clinic.
In DNA double helices elucidated by researchers at University of Cambridge and King's College London, adenine pairs with thymine via two hydrogen bonds; in RNA structures solved by groups at European Synchrotron Radiation Facility adenine pairs with uracil and participates in noncanonical interactions. Structural biology consortia at Wellcome Trust-funded facilities and national synchrotrons have visualized adenine in ribozymes and ribosomal active sites characterized by teams at EMBL-EBI and Ribosome Consortiums. Molecular genetics labs at Broad Institute and Salk Institute exploit adenine-modifying enzymes—such as adenine methyltransferases and deaminases studied by groups at University of California, Berkeley and MIT—for epigenetic regulation, RNA editing, and genomic engineering approaches exemplified by technologies pioneered at Howard Hughes Medical Institute-affiliated labs.
Organic chemists at University of Oxford, Institute of Organic Chemistry and Biochemistry (Prague), and industrial research centers in companies like BASF and Pfizer have developed synthetic routes to adenine and substituted derivatives using methods including condensation of formamide and cyclization of aminopyrimidines. Medicinal chemistry groups at Novartis and GlaxoSmithKline synthesize nucleoside analogs with modified adenine moieties for antiviral and anticancer drug discovery efforts. Structural derivatization strategies using click chemistry and metal-catalyzed cross-coupling have been advanced by teams at ETH Zurich and University of California, Los Angeles to produce labeled adenine probes for imaging at centers like NIH Clinical Center and Advanced Photon Source facilities.
Adenine derivatives underpin therapeutics and diagnostics: antiviral nucleoside analogs developed at Gilead Sciences and Merck target viral polymerases identified in studies at Centers for Disease Control and Prevention and World Health Organization reference labs. Adenine-containing cofactors are central to metabolic therapies and biomarker research performed at Johns Hopkins Hospital and Imperial College London. Biotechnological tools—PCR and sequencing methods refined at Illumina, Thermo Fisher Scientific, and academic groups at University of Washington—rely on adenine nucleotides in reagent formulations. Synthetic biology consortia and biofoundries at Biological Systems Laboratory and DARPA-funded programs explore adenine-modified systems for expanded genetic codes and novel metabolic pathways, with translational work occurring in partnerships between MIT spin-offs and clinical centers such as Mass General Hospital.
Category:Nucleobases